In his latest newsletter, President Cyril Ramaphosa said: “Aspen Pharmacare recently launched its R3.4 billion expansion, which it announced at the 2018 Investment Conference. This investment has turned Aspen’s Gqeberha manufacturing facility into one of largest global manufacturing hubs for general anesthetics and has also provided capacity over 100 million doses of the Johnson & Johnson COVID vaccine have been produced under contract.
The World Health Organization also chose South Africa to host an mRNA vaccine manufacturing hub with the Biovac Institute, which is a public-private partnership with government. South African-born Dr Patrick Soon-Shiong and his company NantWorks recently announced an ambitious initiative to build capacity for advanced health care in Africa. In addition to the investments they will bring, these developments will also contribute to our collective ambition for the continent to manufacture 60% of its vaccine needs by 2040.”
Click here to read the full newsletter.
Photo: GCIS
